Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · CellCept

CellCept 500 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 35–36

HOS-085292 · Präparat HOS-083095

(MedDRA) Renal Hepatic transplant transplant System Organ Class Esophagitis Common Common Eructation Uncommon Uncommon Flatulence Common Very Common Gastritis Common Common Gastrointestinal haemorrhage Common Common Gastrointestinal ulcer Common Common Gingival hyperplasia Common Common Ileus Common Common Mouth ulceration Common Common Nausea Very Common Very Common Pancreatitis Uncommon Common Stomatitis Common Common Vomiting Very Common Very Common Immune system disorders Hypersenstivity Uncommon Common Anaphylactic reactions Not known Not known Hypogammaglobulinaemia Uncommon Very Rare Hepatobiliary disorders Blood alkaline phosphatase increased Common Common Blood lactate dehydrogenase increased Common Uncommon Hepatic enzyme increased Common Very Common Hepatitis Common Very Common Hyperbilirubinaemia Common Very Common Jaundice Uncommon Common Skin and subcutaneous tissue disorders Acne Common Common Alopecia Common Common Rash Common Very Common Skin hypertrophy Common Common Musculoskeletal and connective tissue disorders Arthralgia Common Common Muscular weakness Common Common Renal and urinary disorders Blood creatinine increased Common Very Common Blood urea increased Uncommon Very Common Haematuria Very Common Common Renal impairment Common Very Common General disorders and administration site conditions Asthenia Very Common Very Common Chills Common Very Common Oedema Very Common Very Common Hernia Common Very Common Malaise Common Common 35  Adverse reaction

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.